Insider trading · Q3 2026 · CIK 1674632

Beta Bionics, Inc. (BBNX) insider trading.

In Q3 2026, insiders at Beta Bionics, Inc. reported 16 non-derivative transactions on 13 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $3.2M.

Transactions
16
Purchases (P)
0
Sales (S)
14
Net shares, P minus S
-166,604
Insiders
6
Last filed
2026-09-23

Insiders

InsiderRelationshipTransactionsBuysSales
Hopman MarkOfficer · Chief Commercial Officer505
Feider StephenOfficer · Chief Financial Officer503
Mensinger MikeOfficer · Chief Product Officer202
Saint SeanDirector, Officer · President & CEO202
Jones ChristyDirector101
Russell Steven JonOfficer · Chief Medical Officer101

Transactions

16 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-22Jones ChristyS (D)6,430$2319,564Form 4
2026-09-16Hopman MarkS (D)30,779$20.1356,479Form 4
2026-09-16Mensinger MikeS (D)2,650$22177,390Form 4
2026-09-14Hopman MarkS (D)775$15.5286,382Form 4
2026-09-09Hopman MarkS (D)35,994$18.4688,033Form 4/A
2026-09-09Hopman MarkS (D)36,870$18.4687,157Form 4
2026-09-03Saint SeanS (D)5,641$20.08398,429Form 4
2026-09-02Hopman MarkS (D)5,327$19.11124,027Form 4
2026-09-02Mensinger MikeS (D)4,375$19.11180,040Form 4
2026-09-02Feider StephenS (D)6,675$19.11159,378Form 4
2026-09-02Saint SeanS (D)16,867$19.11404,070Form 4
2026-09-02Russell Steven JonS (D)4,221$19.11169,628Form 4
2026-06-29Feider StephenM (A)4,896$5.1170,949Form 4/A
2026-06-29Feider StephenS (D)4,896$17.03166,053Form 4/A
2026-06-26Feider StephenM (A)5,104$5.1171,157Form 4/A
2026-06-26Feider StephenS (D)5,104$17.05166,053Form 4/A

Transaction codes in this quarter

Get BBNX insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1674632&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · BBNX company page · Beta Bionics, Inc. on SEC.gov

Questions

Are insiders buying or selling Beta Bionics, Inc. (BBNX)?

In Q3 2026, insiders at Beta Bionics, Inc. reported 16 non-derivative transactions on 13 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $3.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Beta Bionics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/bbnx.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.